Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Publication section wording updated to clarify that PubMed-listed publications are automatically populated and to note revision numbers (v3.3.2 vs v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:46:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice that warned about potential delays in updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:30:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Updates are limited to cosmetic and layout changes and do not affect core study information such as design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:08:33.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T08:24:10.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    - Added a new page revision tag (v3.1.0). - Removed a specific medical condition term (Undifferentiated pleomorphic sarcoma).
    Difference
    0.1%
    Check dated 2025-09-29T05:12:36.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. No substantive content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-14T23:20:58.000Z thumbnail image

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.